Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose versus single-dose intravenous tranexamic acid in primary unilateral hip and knee arthroplasty
ChiCTR1800015422Phase 3Recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of tranexamic acid in perioperative bleeding (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoints: Thromboelastography, Deep vein thrombosis rate and 3 more. Started Mar 2018; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
perioperative bleeding
Beyond the preview
Go deeper on ChiCTR1800015422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015422.